China National Biotech Group Company Limited

Beijing, Beijing Shi, China


Purpose

for research and pre-clinical development activities to accelerate the creation and evaluation of a new OPV-2, in which, CNBG will provide their expertise, knowledge and materials for generating new OPV vaccine candidates.

Division

Global Development

Date

November 2013

Region Served

GLOBAL

Committed amount

$225,900

Grant topic

Polio

Duration (months)

38

Grantee location

Beijing, Beijing Shi, China

Related work

Polio

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.